Mesoblast (MESO) Assets Average (2015 - 2025)
Mesoblast's (MESO) quarterly Assets Average came in at $783.5 million in Q4 2025, up 18.49% year-on-year from $661.2 million in Q4 2024, and up 8.97% quarter-over-quarter from $719.0 million in Q2 2025.
Mesoblast (MESO) Assets Average (2015 - 2025) Analysis & Trends
Mesoblast has disclosed Assets Average across 11 years of filings, most recently posting $783.5 million for Q4 2025.
- Assets Average for Q4 2025 came in at $783.5 million, up 18.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $783.5 million (up 18.49% YoY), and the FY2025 annual result was $726.9 million, up 8.61% from the prior year.
- Assets Average came in at $783.5 million for Q4 2025 at Mesoblast, up from $719.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $783.5 million in Q4 2025 to a low of $659.3 million in Q1 2023.
- The 5-year median for Assets Average is $676.3 million (2022), against an average of $697.7 million.
- Across the five-year window, Assets Average fell 11.05% in 2022 and grew 18.49% in 2025, its largest moves.
- Mesoblast's Assets Average stood at $713.1 million in 2021, then dropped by 5.17% to $676.3 million in 2022, then dropped by 0.95% to $669.8 million in 2023, then slipped by 1.29% to $661.2 million in 2024, then advanced by 18.49% to $783.5 million in 2025.
- The last three Assets Average figures came in at $783.5 million (Q4 2025), $719.0 million (Q2 2025), and $661.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | 783.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 783.50 Mn |
| Jun 30, 2025 | 719.00 Mn |
| Dec 31, 2024 | 661.24 Mn |
| Jun 30, 2024 | 669.72 Mn |
| Dec 31, 2023 | 669.85 Mn |
| Jun 30, 2023 | 659.93 Mn |
| Mar 31, 2023 | 659.25 Mn |
| Dec 31, 2022 | 676.28 Mn |
| Sep 30, 2022 | 673.32 Mn |
| Jun 30, 2022 | 671.92 Mn |
| Mar 31, 2022 | 693.06 Mn |
| Dec 31, 2021 | 713.13 Mn |
| Sep 30, 2021 | 733.27 Mn |
| Jun 30, 2021 | 755.42 Mn |
| Mar 31, 2021 | 726.72 Mn |
| Dec 31, 2020 | 699.94 Mn |
| Sep 30, 2020 | 723.09 Mn |
| Jun 30, 2020 | 699.70 Mn |
| Mar 31, 2020 | 678.01 Mn |
| Dec 31, 2019 | 672.01 Mn |